Drugs / PK101-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03553316 | Feb → Mar 2019 | arthritic joint disease | PMG Pharm Co., Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PK101-001 | “IPs for Period2: B (Combination)= PK101-001, PK101-002” NCT03553316 ↗ |